Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$486.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Jun 30 | JAZZ | Jazz Pharmaceuticals plc | FTAX | 4,835 | $237.72 | $1.1M | -3.2% | Open the original filing on SEC.gov |
| Jun 3 | JAZZ | Jazz Pharmaceuticals plc | GGIFT | 600 | — | — | -0.4% | Open the original filing on SEC.gov |
| May 28 | DXCM | Dexcom INC | AGRANT | 5,605 | — | — | +81.5% | Open the original filing on SEC.gov |
| Mar 5 | JAZZ | Jazz Pharmaceuticals plc | FTAX | 7,065 | $188.69 | $1.3M | -4.4% | Open the original filing on SEC.gov |
| Feb 26 | JAZZ | Jazz Pharmaceuticals plc | AGRANT | 44,465 | — | — | +38.6% | Open the original filing on SEC.gov |
| Jan 16 | JAZZ | Jazz Pharmaceuticals plc | FTAX | 5,371 | $171.16 | $919.3K | -4.5% | Open the original filing on SEC.gov |
| Jan 16 | JAZZ | Jazz Pharmaceuticals plc | AGRANT | 12,741 | — | — | +11.8% | Open the original filing on SEC.gov |
| Dec 5, 2025 | JAZZ | Jazz Pharmaceuticals plc | FTAX | 80 | $166.91 | $13.4K | <0.1% | Open the original filing on SEC.gov |
| Aug 7, 2025 | JAZZ | Jazz Pharmaceuticals plc | AGRANT | 18,808 | — | — | +21.1% | Open the original filing on SEC.gov |
| May 8, 2025 | DXCM | Dexcom INC | AGRANT↺ | 1,161 | — | — | +20.3% | Open the original filing on SEC.gov |